Leaflet REDACIB 20mg gastro-resistant tablets

Product code:
W56497001
Quantity:
7
Indicated for:
peptic ulcer; gastroesophageal reflux
Route of administration:
oral
Substance:
pantoprazole (proton pump inhibitor)
ATC
A02BC02 — Alimentary tract and metabolism | Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) | Proton pump inhibitors
Pantoprazole is a proton pump inhibitor used to reduce stomach acid production. It is prescribed for conditions such as gastroesophageal reflux disease (GERD), erosive esophagitis, and gastric or duodenal ulcers.

Pantoprazole effectively relieves symptoms like heartburn, acid regurgitation, and epigastric pain. It is also used to prevent gastric ulcers caused by long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs).

Pantoprazole is generally well-tolerated but may cause side effects such as headaches, nausea, diarrhea, or constipation. Long-term use may increase the risk of bone fractures, vitamin B12 deficiency, and gastrointestinal infections.

Pantoprazole is available as tablets or injectable solutions and should be taken as directed by a doctor. It is important not to stop treatment without medical advice, as symptoms may return.

General data about REDACIB 20mg

Substance:
pantoprazole
Date of latest medicines list:
01-07-2013
Product code:
W56497001
Concentration:
20mg
Pharmaceutical form:
gastro-resistant tablets
Quantity:
7
Product type:
Generic medicine
Prescription status:
OTC — Over the Counter = medicine that does not require a medical prescription.

Marketing authorisation

Manufacturer:
SALUTAS PHARMA GMBH - GERMANIA
Holder:
SANDOZ S.R.L. - ROMANIA
Number:
7671/2015/01
Shelf life:
3 years - after packing for marketing

Concentrations available for pantoprazole

  • 20mg
  • 40mg